Northwestern scientists have created the first highly mature neurons from human induced pluripotent stem cells, a feat that opens new opportunities for medical research and potential transplantation therapies for neurodegenerative diseases.
Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.
Northwestern Medicine investigators have revealed new insights into how cell type switches facilitate tumor growth and treatment resistance in small cell lung cancer, according to findings published in Science Advances.
Scientists have identified new genes linked to heart failure, according to a study published in Nature Communications.
Direct-to-consumer platforms for testosterone therapy don’t always provide care in concordance with professional guidelines, according to a recent Northwestern Medicine study.
Increased levels of the antibody immunoglobulin A (IgA) are correlated with the manifestation of several diseases and African ancestry, according to findings published in Nature Communications.
Patient-reported outcomes in relapsed or refractory large B-cell lymphoma revealed that receiving CAR T-cell immunotherapy was associated with higher quality of life, according to a recent study.
Feinberg experienced a year of outstanding growth, scientific achievement, and collaboration in 2022, from honors and awards to unprecedented research discoveries.
A team of Northwestern investigators led by Peter Penzes, PhD, has developed a new therapy that could treat Phelan-McDermid syndrome, a subtype of autism spectrum disorder.
The Institute for Public Health and Medicine recently hosted its annual Population Health Forum, a celebration of the ten-year anniversary of the institute that brought together hundreds of public health researchers, trainees, and community partners.